Announcement on Progress in Guarantees Provided to Subsidiaries and Guarantees Provided by Subsidiaries
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Progress in Guarantees Provided to Subsidiaries and Guarantees Provided by Subsidiaries
Filed with SSE · · 7 pages · Chinese
Release
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix
Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on the Termination of the Original Lease Contract of the Subsidiary’s Property, Signing of a New Lease Contract, and the Related Party Transaction
- Announcement on Renewal of Drug Production License
- Announcement on Reply to Letter from Shanghai Stock Exchange on Information Disclosure and Supervision
- Announcement on Outline of the 2025 Semi-annual Performance Briefing
Later from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on Expiration of the Plan for Issuance of Stocks to Specific Objects
- Announcement on Obtaining Notice of Approval for Re-Registration of Drug by Wholly-owned Subsidiary
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Progress in Guarantees Provided for the Company's and Its Subsidiary's Application for Comprehensive Credit Line from Banks and Other Financial Institutions in 2025
Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.
Follow Hangzhou Tianmushan Pharmaceutical Enterprise